analyzed the effect of a specifically designed ASO‐22 targeting the 20N PE and the surrounding intronic sequences of the human SCN1A gene, whose de novo mutation results in haploinsufficiency of the α‐1 subunit of the voltage‐gated sodium channel and leads to DS. Here, SCN1A is linked to Dravet syndrome.